Results 1 to 10 of about 5,985 (143)

Facilitators and barriers to seasonal malaria chemoprevention (SMC) uptake in Nigeria: a qualitative approach. [PDF]

Malar J, 2023
Background SMC was adopted in Nigeria in 2014 and by 2021 was being implemented in 18 states, over four months between June and October by 143000 community drug distributors (CDDs) to a target population of 23million children. Further expansion of SMC is
Ogbulafor N, Uhomoibhi P, Shekarau E, Nikau J, Okoronkwo C, Fanou NML, Mbaye IM, Ndiaye JL, Tchouatieu AM, Poku-Awuku A, Merle C, Scott S, Milligan P, Ali A, Yusuf HE, Oguche S, Dahiru T.   +16 more
europepmc   +5 more sources

Impact of seasonal malaria chemoprevention based on the number of medicines doses received on malaria burden among children aged 3–59 months in Nigeria: A propensity score‐matched analysis

Tropical Medicine &International Health, Volume 29, Issue 8, Page 668-679, August 2024.
Seasonal malaria chemoprevention using sulfadoxine‐pyrimethamine plus amodiaquine (sulfadoxine‐pyrimethamine plus amodiaquine on Day 1 and amodiaquine on both Day 2 and Day 3) is delivered to children aged 3–59 months in areas of highly season malaria ...
Sikai Huang, Kevin Baker, Taiwo Ibinaiye, Olusola Oresanya, Chuks Nnaji, S. Richardson   +5 more
semanticscholar   +2 more sources

Evolution of Pfdhps and Pfdhfr mutations before and after adopting seasonal malaria chemoprevention in Nanoro, Burkina Faso. [PDF]

Sci Rep
Seasonal Malaria Chemoprevention consisting of monthly administration of amodiaquine/sulfadoxine-pyrimethamine to children aged 3–59 months during the transmission season could promote SP-resistance.
Bohissou FET, Sondo P, Inoue J, Rouamba T, Kaboré B, Nassa GJW, Kambou AES, Traoré TE, Asua V, Borrmann S, Tinto H, Held J.   +11 more
europepmc   +2 more sources

Urban-rural differences in seasonal malaria chemoprevention coverage and characteristics of target populations in nine states of Nigeria: a comparative cross-sectional study. [PDF]

Malar J
Background Differences between urban and rural contexts in terms of sociodemographic characteristics, geographical features and risk perceptions may lead to disparities in coverage and related outcomes of community-based preventive interventions, such as
Ibinaiye T, Rotimi K, Balogun A, Aidenagbon A, Oguoma C, Baker K, Ogunmola O, Oresanya O, Rassi C, Nnaji C.   +9 more
europepmc   +2 more sources

A quasi-experimental study to estimate effectiveness of seasonal malaria chemoprevention in Aweil South County in Northern Bahr El Ghazal, South Sudan. [PDF]

Malar J
Background Seasonal malaria chemoprevention (SMC) is an effective intervention to prevent malaria in children in locations where the burden of malaria is high and transmission is seasonal.
Khan J, Suau Sans M, Okot F, Rom Ayuiel A, Magoola J, Rassi C, Huang S, Mubiru D, Bonnington C, Baker K, Ahmed J, Nnaji C, Richardson S.   +12 more
europepmc   +2 more sources

The monthly trends of malaria cases in children under 5 years of age in Guinea: comparative analysis between a seasonal malaria chemoprevention (SMC) and a non-SMC health district. [PDF]

Malar J
Background The Republic of Guinea, where malaria represents the leading cause of morbidity and mortality among children, the seasonal malaria chemoprevention (SMC) is deployed only in areas with very seasonal modes of transmission.
Keita KS, Camara BS, Camara S, Barry F, Sidibe T, Kourouma K, Diallo R, Toure M, Camara A, Balde MD.   +9 more
europepmc   +2 more sources

Predictors of accessing seasonal malaria chemoprevention medicines through non-door-to-door distribution in Nigeria [PDF]

Malar J
Background In Nigeria, seasonal malaria chemoprevention (SMC) is typically administered door-to-door to children under five by community medicine distributors during high transmission seasons. While door-to-door distribution (DDD) is exclusively employed
Huang S, Baker K, Ibinaiye T, Oresanya O, Nnaji C, Richardson S.   +5 more
europepmc   +2 more sources

Examination of factors impacting spitting or vomiting among children under 5 years of age during seasonal malaria chemoprevention: a quantitative study in Burkina Faso, Chad, Nigeria and Togo. [PDF]

Trop Med Health
Background Since 2012, the World Health Organization has recommended seasonal malaria chemoprevention (SMC) with sulfadoxine-pyrimethamine plus amodiaquine (SPAQ) for children aged 3–⁠59 months in regions where malaria transmission is seasonal.
Gao C, Huang S, Ibinaiye T, Sawadogo B, Traore A, Compaoré CS, Awokou F, Nnaji CA, Baker K, Wang D, Richardson S.   +10 more
europepmc   +2 more sources

Seasonal Malaria Chemoprevention Drug Levels and Drug Resistance Markers in Children With or Without Malaria in Burkina Faso: A Case-Control Study. [PDF]

J Infect Dis, 2023
BACKGROUND Despite scale-up of seasonal malaria chemoprevention (SMC) with sulfadoxine-pyrimethamine and amodiaquine (SP-AQ) in children
Roh ME, Zongo I, Haro A, Huang L, Somé AF, Yerbanga RS, Conrad MD, Wallender E, Legac J, Aweeka F, Ouédraogo JB, Rosenthal PJ.   +11 more
europepmc   +2 more sources

Seasonal malaria chemoprevention in a context of high presumed sulfadoxine-pyrimethamine resistance: malaria morbidity and molecular drug resistance profiles in South Sudan. [PDF]

Malar J, 2023
Background Seasonal malaria chemoprevention (SMC) using sulfadoxine-pyrimethamine plus amodiaquine (SP-AQ), is a community-based malaria preventive strategy commonly used in the Sahel region of sub-Saharan Africa.
Molina-de la Fuente I, Sagrado Benito MJ, Lasry E, Ousley J, García L, González V, Pasquale HA, Julla A, Uwiragiye P, Abdi AM, Chol BT, Abubakr B, Benito A, Casademont C, Berzosa P, Nanclares C.   +15 more
europepmc   +2 more sources